Remibrutinib

CAS No. 1787294-07-8

Remibrutinib( —— )

Catalog No. M23801 CAS No. 1787294-07-8

Remibrutinib inhibits BTK activity with an IC50 value of 0.023 μM in blood.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 210 In Stock
10MG 340 In Stock
25MG 572 In Stock
50MG 797 In Stock
100MG 1107 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Remibrutinib
  • Note
    Research use only, not for human use.
  • Brief Description
    Remibrutinib inhibits BTK activity with an IC50 value of 0.023 μM in blood.
  • Description
    Remibrutinib inhibits BTK activity with an IC50 value of 0.023 μM in blood. Remibrutinib is an effective and orally active Bruton tyrosine kinase inhibitor (IC50: 1 nM). Remibrutinib has the potential for Chronic urticaria (CU) treatment.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Tyrosine Kinase
  • Target
    BTK
  • Recptor
    BTK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1787294-07-8
  • Formula Weight
    507.53
  • Molecular Formula
    C27H27F2N5O3
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:125 mg/mL (246.29 mM; Need ultrasonic)
  • SMILES
    CC1=C(C=C(C=C1NC(=O)C2=C(C=C(C=C2)C3CC3)F)F)C4=C(C(=NC=N4)N)OCCN(C)C(=O)C=C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Daniela Angst, et al. Novel amino pyrimidine derivatives. Patent WO2015079417A1.
molnova catalog
related products
  • BLK degrader 1

    BLK degrader 1 is a selective B lymphoid tyrosine kinase (BLK) degrader with anticancer activity and can be used for cancer research.

  • Tolebrutinib

    Tolebrutinib is a potent, selective, orally active and brain-penetrant Bruton tyrosine kinase (BTK) inhibitor(IC50s of 0.4 and 0.7 nM in Ramos B cells and in HMC microglia cells, respectively).

  • Acalabrutinib enanti...

    Acalabrutinib enantiomer (R-Acalabrutinib) is a chemical compound that belongs to the class of Bruton’s tyrosine kinase (BTK) inhibitors.